Fundz

Know Labs

Seattle, WA, United States · Biotechnology, Blockchain, Financial Services · 9 employees

Know Labs is transforming non-invasive medical diagnostics. The proprietary technology platform uses radiofrequency (RF) dielectric spectroscopy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application is a non-invasive continuous blood glucose monitoring device that will provide the user with real-time information on their blood glucose levels, as

Funding history

  • Funding Round — $119.9M — Aug 2025
  • Funding Round — $12.0M — Feb 2024
  • Series pre-seed — $80K — Dec 2022
  • Series seed — $255K — Jun 2022
  • Funding Round — $14.3M — Mar 2021

Recent signals

  • Jun 01, 2026: SEC 8-K (2.03): On June 1, 2026, USBC, Inc. entered into a financial obligation by drawing an additional fixed-rate borrowing of $5.0 million under its Master Loan Agreement with Payward Interactive, increasing the total amount borrowed to $15.0 million. The loan agreement allows for borrowings up to $25.0 million and bears an interest rate of 8.5% per annum, with a maturity date of June 1, 2027. The borrowed funds are secured by Bitcoin collateral held in custody with Payward Financial, Inc., and are subject to standard collateral maintenance provisions, including margin requirements and liquidation rights. This draw demonstrates USBC's effort to leverage its loan capacity while managing financial liquidity and operational needs.
  • Mar 24, 2026: USBC, INC. Announces Stock Option Repricing for Executive Officers
  • Mar 18, 2026: SEC 8-K (5.02): On March 18, 2026, USBC, Inc. approved the repricing of 83.0 million stock options under the Amended and Restated 2021 Equity Incentive Plan. The repricing reduced the exercise price to $0.37 per share, which corresponds to the closing price of the company's stock on that date. This decision aimed to motivate and retain named executive officers and directors to enhance the company's performance. The action taken by the Board underscores the company's commitment to aligning the interests of employees with those of its stockholders.
  • Nov 19, 2025: SEC 8-K (5.02): On November 19, 2025, John Cronin resigned from the Board of Directors of USBC, Inc. His resignation was not due to any disagreements with the Company or its management regarding operations, policies, or practices. This change in the Board of Directors may signal potential shifts in governance or strategic direction, although the specific implications of his departure are not detailed in the filing.
  • Aug 21, 2025: Raised $119.9M
  • Oct 22, 2024: Know Labs, Inc. Appoints John Cronin as Interim Chief Technology Officer and Dominic Klyve, Ph.D. as Chief Science Officer
  • Oct 16, 2024: Launched Know Labs, Inc. Unveils Non-Invasive Sensor Technology for Alcohol Detection in Steering Wheels.
  • Aug 16, 2024: Know Labs, Inc. Announces $1.655 Million Public Offering

See plans & pricing → Track Know Labs’s funding, hiring, and signals — with verified contacts — on Fundz.